Federal Register / Vol. 82, No. 191 / Wednesday, October 4, 2017 / Notices 46245 

VOCs that affect outdoor air quality. 

Consistent with the Green Guides, the 

order defines ‘‘trace level of emissions’’ 

for claims for a substance to mean that 

(1) emissions of the substance do not 

result in inhalation concentrations of 

that substance higher than background 

levels in the typical residential home; 

(2) emissions of the substance do not 

cause material harm that consumers 

typically associate with that substance, 

including harm to the environment or 

human health; and (3) the substance has 

not been added intentionally to the 

covered product. 

Part III prohibits respondent from 

mispresenting the results of any tests or 

studies, or from misrepresenting that 

any product benefit is scientifically or 

clinically proven. Parts IV and V 

prohibit respondent from 

misrepresenting certifications or failing 

to adequately disclose a material 

connection to a party making a 

representation, e.g., an endorser. 

Parts VI through X are reporting and 

compliance provisions. Part VI 

mandates that respondent acknowledge 

receipt of the order, distribute the order 

to certain employees and agents, and 

secure acknowledgments from 

recipients of the order. Part VII requires 

that respondent submit compliance 

reports to the FTC within ninety (90) 

days of the order’s issuance and submit 

additional reports when certain events 

occur. Part VIII requires that respondent 

create and retain certain records for five 

(5) years. Part IX provides for the FTC’s 

continued compliance monitoring of 

respondent’s activity during the order’s 

effective dates. Part X is a provision 

‘‘sunsetting’’ the order after twenty (20) 

years, with certain exceptions. 

The purpose of the analysis is to aid 

public comment on the proposed order. 

It is not intended to constitute an 

official interpretation of the proposed 

order or to modify its terms in any way. 

By direction of the Commission. 

Donald S. Clark, 

Secretary. 

[FR Doc. 2017–21289 Filed 10–3–17; 8:45 am] 

BILLING CODE 6750–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Medicare & Medicaid 

Services 

[Document Identifiers: CMS–10110] 

Agency Information Collection 

Activities: Submission for OMB 

Review; Comment Request 

AGENCY: Centers for Medicare & 

Medicaid Services, HHS. 

ACTION: Notice. 

SUMMARY: The Centers for Medicare & 

Medicaid Services (CMS) is announcing 

an opportunity for the public to 

comment on CMS’ intention to collect 

information from the public. Under the 

Paperwork Reduction Act of 1995 

(PRA), federal agencies are required to 

publish notice in the Federal Register 

concerning each proposed collection of 

information, including each proposed 

extension or reinstatement of an existing 

collection of information, and to allow 

a second opportunity for public 

comment on the notice. Interested 

persons are invited to send comments 

regarding the burden estimate or any 

other aspect of this collection of 

information, including the necessity and 

utility of the proposed information 

collection for the proper performance of 

the agency’s functions, the accuracy of 

the estimated burden, ways to enhance 

the quality, utility, and clarity of the 

information to be collected; and the use 

of automated collection techniques or 

other forms of information technology to 

minimize the information collection 

burden. 

DATES: Comments on the collection(s) of 

information must be received by the 

OMB desk officer by November 3, 2017. 

ADDRESSES: When commenting on the 

proposed information collections, 

please reference the document identifier 

or OMB control number. To be assured 

consideration, comments and 

recommendations must be received by 

the OMB desk officer via one of the 

following transmissions: OMB, Office of 

Information and Regulatory Affairs, 

Attention: CMS Desk Officer, Fax 

Number: (202) 395–5806 OR Email: 

OIRA_submission@omb.eop.gov. 

To obtain copies of a supporting 

statement and any related forms for the 

proposed collection(s) summarized in 

this notice, you may make your request 

using one of following: 

1. Access CMS’ Web site address at 

Web site address at https://

www.cms.gov/Regulations-andGuidance/Legislation/

PaperworkReductionActof1995/PRAListing.html. 

2. Email your request, including your 

address, phone number, OMB number, 

and CMS document identifier, to 

Paperwork@cms.hhs.gov. 

3. Call the Reports Clearance Office at 

(410) 786–1326. 

FOR FURTHER INFORMATION CONTACT: 

William Parham at (410) 786–4669. 

SUPPLEMENTARY INFORMATION: Under the 

Paperwork Reduction Act of 1995 (PRA) 

(44 U.S.C. 3501–3520), federal agencies 

must obtain approval from the Office of 

Management and Budget (OMB) for each 

collection of information they conduct 

or sponsor. The term ‘‘collection of 

information’’ is defined in 44 U.S.C. 

3502(3) and 5 CFR 1320.3(c) and 

includes agency requests or 

requirements that members of the public 

submit reports, keep records, or provide 

information to a third party. Section 

3506(c)(2)(A) of the PRA (44 U.S.C. 

3506(c)(2)(A)) requires federal agencies 

to publish a 30-day notice in the 

Federal Register concerning each 

proposed collection of information, 

including each proposed extension or 

reinstatement of an existing collection 

of information, before submitting the 

collection to OMB for approval. To 

comply with this requirement, CMS is 

publishing this notice that summarizes 

the following proposed collection(s) of 

information for public comment: 

1. Type of Information Collection 

Request: Revision of a currently 

approved collection; Title of 

Information Collection: Manufacturer 

Submission of Average Sales Prices 

(ASP) Data for Medicare Part B Drugs; 

Use: In accordance with Section 1847A 

of the Social Security Act (the Act), 

Medicare Part B covered drugs and 

biologicals not paid on a cost or 

prospective payment basis are paid 

based on the average sales price (ASP) 

of the drug or biological, beginning in 

Calendar Year (CY) 2005. The ASP data 

reporting requirements are specified in 

Section 1927 of the Act. The reported 

ASP data are used to establish the 

Medicare payment amounts. Form 

Number: CMS–10110 (OMB control 

number: 0938–0921); Frequency: 

Quarterly; Affected Public: Business or 

other For-profits; Number of 

Respondents: 180; Total Annual 

Responses: 720; Total Annual Hours: 

9360. (For policy questions regarding 

this collection contact Felicia Eggleston 

at 410–786–9287.) 

Dated: September 28, 2017. 

William N. Parham, III, 

Director, Paperwork Reduction Staff, Office 

of Strategic Operations and Regulatory 

Affairs. 

[FR Doc. 2017–21249 Filed 10–3–17; 8:45 am] 

BILLING CODE 4120–01–P 


sradovich on DSK3GMQ082PROD with NOTICES